Drugs / LV009
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07330895 | Dec 2025 → Dec 2027 expected | B-cell acute lymphoblastic leukemia | The First Affiliated Hospital with Nanjing Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07330895 ↗ |